Perrigo cuts 2026 outlook, speeds through Infant Formula sale
Perrigo lowered its full-year 2026 outlook due to Europe's softness and measured retail inventory positioning, although the company reported sequential market share gains and higher adjusted earnings in Q3 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed